These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 19298916

  • 1. Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide.
    Morikawa S, Sone T, Tsuboi H, Mukawa H, Morishima I, Uesugi M, Morita Y, Numaguchi Y, Okumura K, Murohara T.
    J Am Coll Cardiol; 2009 Mar 24; 53(12):1040-6. PubMed ID: 19298916
    [Abstract] [Full Text] [Related]

  • 2. Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.
    Kim BJ, Sung KC, Kim BS, Kang JH, Lee KB, Kim H, Lee MH.
    Int J Cardiol; 2010 Feb 04; 138(3):239-45. PubMed ID: 18793808
    [Abstract] [Full Text] [Related]

  • 3. Effects of atrial natriuretic peptide versus mannitol on renal blood flow during radiocontrast infusion in chronic renal failure.
    Kurnik BR, Weisberg LS, Cuttler IM, Kurnik PB.
    J Lab Clin Med; 1990 Jul 04; 116(1):27-36. PubMed ID: 2142949
    [Abstract] [Full Text] [Related]

  • 4. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
    Oldemeyer JB, Biddle WP, Wurdeman RL, Mooss AN, Cichowski E, Hilleman DE.
    Am Heart J; 2003 Dec 04; 146(6):E23. PubMed ID: 14661012
    [Abstract] [Full Text] [Related]

  • 5. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease.
    Toprak O, Cirit M, Esi E, Postaci N, Yesil M, Bayata S.
    Catheter Cardiovasc Interv; 2006 Feb 04; 67(2):227-35. PubMed ID: 16400673
    [Abstract] [Full Text] [Related]

  • 6. Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
    Toso A, Maioli M, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, Manzone C, Amato M, Bellandi F.
    Am J Cardiol; 2010 Feb 01; 105(3):288-92. PubMed ID: 20102936
    [Abstract] [Full Text] [Related]

  • 7. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
    Jo SH, Koo BK, Park JS, Kang HJ, Kim YJ, Kim HL, Chae IH, Choi DJ, Sohn DW, Oh BH, Park YB, Choi YS, Kim HS.
    Am Heart J; 2009 Mar 01; 157(3):576-83. PubMed ID: 19249432
    [Abstract] [Full Text] [Related]

  • 8. B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention.
    Zhang J, Fu X, Jia X, Fan X, Gu X, Li S, Wu W, Fan W, Su J, Hao G, Jiang Y, Xue L.
    Acta Radiol; 2010 Jul 01; 51(6):641-8. PubMed ID: 20438292
    [Abstract] [Full Text] [Related]

  • 9. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
    Calabrò P, Bianchi R, Caprile M, Sordelli C, Cappelli Bigazzi M, Palmieri R, Gigantino G, Limongelli G, Capozzi G, Cuomo S, Calabrò R.
    Minerva Cardioangiol; 2010 Feb 01; 58(1):35-40. PubMed ID: 20145594
    [Abstract] [Full Text] [Related]

  • 10. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
    Majumdar SR, Kjellstrand CM, Tymchak WJ, Hervas-Malo M, Taylor DA, Teo KK.
    Am J Kidney Dis; 2009 Oct 01; 54(4):602-9. PubMed ID: 19535188
    [Abstract] [Full Text] [Related]

  • 11. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Maioli M, Toso A, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, Bellandi F.
    J Am Coll Cardiol; 2008 Aug 19; 52(8):599-604. PubMed ID: 18702961
    [Abstract] [Full Text] [Related]

  • 12. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial.
    Ozcan EE, Guneri S, Akdeniz B, Akyildiz IZ, Senaslan O, Baris N, Aslan O, Badak O.
    Am Heart J; 2007 Sep 19; 154(3):539-44. PubMed ID: 17719303
    [Abstract] [Full Text] [Related]

  • 13. Effect of dopamine on renal function after arteriography in patients with pre-existing renal insufficiency.
    Hans SS, Hans BA, Dhillon R, Dmuchowski C, Glover J.
    Am Surg; 1998 May 19; 64(5):432-6. PubMed ID: 9585778
    [Abstract] [Full Text] [Related]

  • 14. Reno-protective effect of N-acetyl cysteine in patients with impaired renal function undergoing coronary angiography and interventions.
    Ramesh N, Pillai RK, Abraham T, Padmaja NP, Hameed S, Vijayaraghavan G.
    J Assoc Physicians India; 2006 Jun 19; 54():449-52. PubMed ID: 16909692
    [Abstract] [Full Text] [Related]

  • 15. Contrast-induced nephrotoxicity in renal allograft recipients.
    Ahuja TS, Niaz N, Agraharkar M.
    Clin Nephrol; 2000 Jul 19; 54(1):11-4. PubMed ID: 10939751
    [Abstract] [Full Text] [Related]

  • 16. [Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].
    Hoshino A, Enomoto S, Kawahito H, Kurata H, Nakahara Y, Nakamura T.
    J Cardiol; 2007 Aug 19; 50(2):119-26. PubMed ID: 17802695
    [Abstract] [Full Text] [Related]

  • 17. Frequency and predictors of contrast-induced nephropathy after angioplasty for chronic total occlusions.
    Aguiar-Souto P, Ferrante G, Del Furia F, Barlis P, Khurana R, Di Mario C.
    Int J Cardiol; 2010 Feb 18; 139(1):68-74. PubMed ID: 19056138
    [Abstract] [Full Text] [Related]

  • 18. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions.
    Khanal S, Attallah N, Smith DE, Kline-Rogers E, Share D, O'Donnell MJ, Moscucci M.
    Am J Med; 2005 Aug 18; 118(8):843-9. PubMed ID: 16084176
    [Abstract] [Full Text] [Related]

  • 19. N-acetylcysteine versus N-acetylcysteine + theophylline for the prevention of contrast nephropathy.
    Baskurt M, Okcun B, Abaci O, Dogan GM, Kilickesmez K, Ozkan AA, Ersanli M, Gurmen T.
    Eur J Clin Invest; 2009 Sep 18; 39(9):793-9. PubMed ID: 19500141
    [Abstract] [Full Text] [Related]

  • 20. Effect of 1-28 alpha-h atrial natriuretic peptide on acute renal failure in cadaveric renal transplantation.
    Gianello P, Carlier M, Jamart J, Hulhoven R, Bernheim J, Bernard A, Ketelslegers JM, Squifflet JP.
    Clin Transplant; 1995 Dec 18; 9(6):481-9. PubMed ID: 8645892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.